How to Apply Careprost and Latisse to Eyelashes: The Label Method, Step by Step
SafeRxPills Pharmacy Team
Editorial team at SafeRxPills. Articles are written and checked against regulatory drug labelling (DailyMed, FDA, EMA) and published literature.

How to Apply Careprost Eyelash Serum: Step-by-Step Guide | SafeRxPills - pharmacy guide
In this article (27 sections)
Careprost is a bimatoprost 0.03% eye drop made in India by Sun Pharmaceutical Industries. It is sold there as a glaucoma medicine, and the bottle comes without any lash applicators or lash instructions. Latisse, the US product approved for thin or short eyelashes, contains the same drug at the same strength, and its US label sets out exactly how it should be applied. That label is the closest written guide anyone has for putting Careprost on the lashes.
This page walks through the Latisse application method one step at a time, explains the reason behind each rule, and says plainly where using a Careprost bottle differs from using a Latisse kit. It also covers contact lenses, other eye drops, missed nights, when you can judge whether your technique is working, side effects with their trial rates, and what our bimatoprost products cost as of 28 October 2026. We sell Careprost and other bimatoprost 0.03% bottles, so we have a commercial interest; every number below comes from the FDA label, a published trial or a dated price source listed under Sources.
The short answer
Once a night, on a clean face with makeup and contact lenses removed, put one drop of bimatoprost 0.03% on a sterile single-use applicator. Draw it along the skin of the upper eyelid margin, where the lashes meet the skin, from the inner corner to the outer corner. The lid should feel lightly moist, with nothing running off. Blot any excess with a tissue, throw the applicator away, and use a new one for the other eye. Do not apply it to the lower lash line and do not put it in the eye. Contact lenses can go back in after 15 minutes.
The Latisse label adds that extra applications will not grow lashes any faster, and that lashes go back to how they were after you stop. In the trial behind the approval, half of users had a visible improvement by week 8 and 78% by week 16.
Why the Latisse label is the guide for Careprost
Latisse (AbbVie, originally Allergan) was approved by the FDA on 24 December 2008 to treat hypotrichosis of the eyelashes, meaning too few or too short lashes. Its label describes the solution as bimatoprost 0.3 mg per mL, which is the same 0.03% strength printed on a Careprost bottle. Careprost's own pack is written for glaucoma: the Indian pharmacy chain Netmeds lists it under antiglaucoma preparations, as a Schedule H medicine and marks it as requiring a prescription.
Careprost was not the product tested in the Latisse trials, and no regulator has reviewed it for lash use. What it shares with Latisse is the active ingredient and its strength. Following the Latisse method as closely as you can is the nearest way to match the conditions behind the published results and the known side effect rates. Our Careprost vs Latisse comparison covers the differences between the two products, and Lumigan vs Careprost explains the glaucoma side.
What comes in the box: a Latisse kit vs a Careprost bottle
The practical difference shows up as soon as you open the pack. The Latisse label says it is supplied as a sterile solution in a white dropper bottle together with sterile, disposable applicators: 70 with the 3 mL bottle and 140 with the 5 mL bottle.
| Item | Latisse 3 mL (US) | Careprost 3 mL (India) |
|---|---|---|
| Active ingredient | Bimatoprost 0.3 mg/mL (0.03%) | Bimatoprost 0.03% |
| Labelled use | Eyelash hypotrichosis | Glaucoma (antiglaucoma preparation) |
| Applicators in the pack | 70 sterile, disposable applicators | None in the pack we sell |
| Lash instructions | Full method in the label and patient leaflet | Not on the pack |
| Preservative | Benzalkonium chloride 0.05 mg/mL | Check the carton of your bottle |
Seventy applicators at two per night covers 35 nights; the label does not say how many nights a 3 mL bottle lasts. The Latisse 5 mL bottle comes with 140 applicators. Some US generic lash versions are also packed with applicators: the FDA's NDC directory lists the Sandoz bimatoprost 0.03% product as "BOTTLE, WITH APPLICATOR".
Applicators: what the label says and what that means for Careprost
The Latisse label is strict here. It tells users to apply the drop with "the disposable sterile applicator supplied with the package", to "dispose of the applicator after one use", and adds: "Do not reuse applicators and do not use any other brush/applicator to apply LATISSE." The reason it gives is contamination: reusing applicators "increases the potential for contamination and infections", and the label notes reports of bacterial keratitis, an infection of the cornea, linked to multiple-dose eye products.
Because Careprost has no supplied applicator, nobody using it can follow that sentence word for word. The nearest you can get to the intent of the rule is a sealed, sterile, single-use applicator, a new one for each eye, thrown away after use. A reused mascara wand, an eyeliner brush or a fingertip is the opposite of what the label describes: they carry bacteria and cosmetic residue to the lid margin and back into your routine every night. To be clear, sterile applicators bought separately have not been tested with Careprost in any trial; they simply follow the label's hygiene logic more closely than a reused brush does.
What you need before you start
- Your bottle of bimatoprost 0.03%, with the seal intact and within its expiry date.
- Sterile, single-use applicators: two for each night.
- Clean tissues or another absorbent material for blotting.
- A mirror in good light, so you can see the exact base of the lashes.
- Makeup remover and your contact lens case, if you wear lenses.
Wash your hands before you begin. The label asks that the face be clean and that makeup and contact lenses are removed before every application.
Step by step: the label method
- Prepare. Remove all eye makeup, wash your face and take out contact lenses.
- Load the applicator. Take a new sterile applicator and hold it horizontally. Place one drop on the part of the applicator closest to the tip, but not on the tip itself. Do not let the bottle tip touch the applicator, your fingers or anything else.
- Apply straight away. Draw the applicator carefully across the skin of the upper eyelid margin at the base of the lashes, from the inner part of the lash line to the outer part.
- Check the amount. The label says the lid margin "should feel lightly moist without runoff".
- Blot. Wipe away any solution that has spread beyond the upper lid margin with a tissue.
- Discard. Throw the applicator away after this one eye.
- Repeat. Use a new sterile applicator and a new drop for the other upper lid. The patient leaflet says this "helps minimize any potential for contamination from one eyelid to another".
- Close the bottle and store it as described further down.
One drop per eye, and why more does not help
Each eye gets one drop, placed on the applicator rather than dripped onto the lid. The label says twice that more is not better: "Additional applications of LATISSE will not increase the growth of eyelashes", and the patient leaflet adds that using it more than once a day "will not increase the growth of eyelashes more than use once a day".
Extra solution is not harmless either. It is the excess that runs onto the cheek or the eyelid skin, where it can darken skin or grow hair in places you did not want it. Bimatoprost used as a glaucoma drop also shows the effect of too much exposure: the label notes that in Lumigan studies, giving the eye more than one dose a day "may decrease the intraocular pressure lowering effect".
Upper lid only: why not the lower lash line
The label says "Do not apply to the lower eyelash line", and the patient leaflet prints "DO NOT APPLY" in capitals for the lower lid. The cross-references point to the warnings on eyelid skin darkening and hair growth outside the treatment area. Applying there adds skin exposure without any tested benefit: the label's method and its trial results come from application to the upper lid margin.
Blotting runoff and hair outside the treatment area
Section 5.4 of the label warns that "there is the potential for hair growth to occur in areas where LATISSE solution comes in repeated contact with the skin surface". It asks users to apply the solution only to the upper eyelid margin and "to carefully blot any excess" so it does not run onto the cheek or other skin. Two habits make the difference:
- Use a single drop, so there is little to run off in the first place.
- Blot at the outer corner, where runoff tends to collect, every night.
The label also warns that lashes may grow unevenly between the two eyes: differences in length, thickness, colour, number of lashes or direction of growth. Applying the same way to both lids each night is the practical way to keep them even, and the label says these changes are likely reversible after stopping.
Keeping the bottle and applicators clean
The label tells users to keep the bottle intact and not to let the tip of the bottle or the applicator touch "surrounding structures, fingers, or any other unintended surface", to avoid contamination "by common bacteria known to cause ocular infections". It adds that "serious infections may result from using contaminated solutions or applicators". In practice:
- Squeeze the drop onto the applicator from just above it, without contact.
- Put the cap back on straight away.
- Never share a bottle or an applicator with anyone else.
- Never put a used applicator back into a pack or reuse it the next night.
If some gets in your eye
This worries a lot of new users, and the label answer is reassuring: "If any LATISSE solution gets into the eye proper, it will not cause harm. The eye should not be rinsed." Bimatoprost 0.03% is, after all, the strength used as a glaucoma eye drop. Do not try to wash it out; carry on with the other eye using a fresh applicator. The one thing to watch for is an eye that stays red, painful or blurred, which is a reason to stop and see a doctor.
Contact lenses: out first, back in after 15 minutes
The Latisse label says the solution contains benzalkonium chloride, a preservative "which may be absorbed by and cause discoloration of soft contact lenses". Lenses should be taken out before applying and "may be reinserted 15 minutes following its administration". Since the label method is a nightly routine, most lens wearers simply apply it after taking their lenses out for the night. If your Careprost carton lists a different preservative, the same 15 minute wait is a sensible default.
Using it alongside glaucoma drops or other eye drops
This is the interaction that matters most. The label warns that in people using Lumigan or other prostaglandin analogs to lower eye pressure, adding Latisse "may interfere with the desired reduction in IOP". People on these drops "should only use LATISSE after consulting with their physician and should be monitored for changes to their intraocular pressure". The patient leaflet says the same applies if you have a history of abnormal eye pressure.
Careprost is itself a prostaglandin analog glaucoma drop. If you use any eye pressure drop, check with the doctor who prescribed it whether it belongs to this group, and speak to them before starting lash treatment.
For people without glaucoma, the label says Latisse lowered eye pressure in trials, but "the magnitude of the reduction was not cause for clinical concern". It still asks users to tell their doctor, and "anyone conducting an eye pressure screening", that they use it, because a lower reading could otherwise be misread.
Timing and missed nights
The label dose is once nightly. Evening use fits the method: makeup and lenses are already out, and the solution has the night to dry on the lid margin. If you miss a night, the patient leaflet is clear: "don't try to catch up. Just apply LATISSE solution the next evening." There is no instruction to double up, and doubling up would only add runoff.
How long before you can judge your technique
Lashes grow slowly, so the first weeks tell you very little. The label says the onset "is gradual but is not significant in the majority of patients until 2 months". Its main trial, in 278 adults over 16 weeks, scored lashes on the 4-point Global Eyelash Assessment, where a 1-grade gain means a visible change in overall lash prominence.
| Week of nightly use | Bimatoprost 0.03% (n=137) | Vehicle (n=141) |
|---|---|---|
| Week 1 | 7 (5%) | 3 (2%) |
| Week 4 | 20 (15%) | 11 (8%) |
| Week 8 | 69 (50%) | 21 (15%) |
| Week 12 | 95 (69%) | 28 (20%) |
| Week 16 | 107 (78%) | 26 (18%) |
At week 16, average lash length had risen by 25% (1.4 mm) against 2% on vehicle, fullness by 106% against 12%, and darkness by 18% against 3%. So if you have applied the label way every night, judge the result at around 8 weeks, and give it the full 16 before deciding it has not worked. Our Careprost results week by week guide goes through the timeline in more detail.
Stopping, and keeping the results
The label says that on stopping, "eyelash growth is expected to return to its pre-treatment level". The patient leaflet puts it as "over several weeks to months". A 12-month randomized trial (Glaser 2015) measured this directly in 60 adults who used bimatoprost 0.03% nightly for 6 months and were then switched, without knowing, to an inactive vehicle.
| Month | Treatment | At least 1-grade gain (n=60) |
|---|---|---|
| 1 | Bimatoprost | 6 (10.0%) |
| 2 | Bimatoprost | 24 (40.0%) |
| 4 | Bimatoprost | 43 (71.7%) |
| 6 | Bimatoprost | 46 (76.7%) |
| 7 | Vehicle | 47 (78.3%) |
| 8 | Vehicle | 47 (78.3%) |
| 10 | Vehicle | 28 (46.7%) |
| 12 | Vehicle | 21 (35.0%) |
The authors summarised it as effects "maintained for approximately 2 months but markedly diminished 4-6 months following treatment cessation". In the same trial, people who kept using bimatoprost for the full year held their month 6 results at month 12. The method is a routine, not a course: results last as long as the nightly application does.
Side effects, and how application affects them
In the 278-patient Latisse trial, the label lists the most frequent adverse reactions as eye itching, eye redness (conjunctival hyperemia), skin darkening, eye irritation, dry eye symptoms and redness of the eyelids, each occurring "in less than 4% of patients". The patient leaflet puts itching and/or redness of the eyes at "approximately 4%". The longer trial gives figures for up to a year of nightly use in 118 adults (118 in months 0 to 6, 106 in months 6 to 12):
| Adverse event, 0 to 12 months | Idiopathic hypotrichosis (n=118) |
|---|---|
| Conjunctival hyperaemia (red eyes) | 10 (8.5%) |
| Eyelid pruritus (itchy eyelids) | 7 (5.9%) |
| Erythema of eyelid (red eyelids) | 6 (5.1%) |
| Punctate keratitis | 3 (2.5%) |
| Skin hyperpigmentation | 2 (1.7%) |
| Eye pruritus (itchy eyes) | 1 (0.8%) |
All six are in the eye or the eyelid skin, the places the solution reaches. That is why technique matters. One drop, a sterile applicator, the upper lid margin and careful blotting all reduce the amount that reaches skin and eye. After approval, the label also lists reports of eyelid swelling, styes, local allergic reactions, temporary loss or breakage of some lashes, dry eyelid skin, and changes around the eye linked to loss of fat (a deeper eyelid crease and a drooping lid). The safety picture is covered in full in our guide to lash serum safety.
Iris colour and eyelid darkening
Two pigment effects are worth knowing about before you start, because one of them does not reverse.
- Iris colour. The label warns of "increased brown iris pigmentation which is likely to be permanent". It may not be noticeable "for several months to years", and typically starts around the pupil and spreads outward. The patient leaflet says iris darkening "is NOT expected to reverse".
- Eyelid skin. Bimatoprost can darken the skin around the eye. The label says this is expected to increase as long as it is used, but has been "reversible upon discontinuation of bimatoprost in most patients".
Applying to the outer skin of the upper lid margin, rather than into the eye, is how the trials were run. People with light-coloured eyes should weigh the iris warning before starting.
Who should not use it, or should ask a doctor first
- Contraindicated: anyone with hypersensitivity to bimatoprost or any of the ingredients, including the preservative.
- Ask your doctor first: anyone using Lumigan or another prostaglandin analog for eye pressure, or with a history of abnormal eye pressure.
- Use with caution: active eye inflammation such as uveitis, which the label says "may be exacerbated"; and people at risk of macular edema, including those without a natural lens (aphakic) or with an artificial lens and a torn posterior lens capsule.
- Pregnancy: the label says it should be used in pregnancy "only if the potential benefit justifies the potential risk to the fetus". For a cosmetic treatment, that is a conversation to have with your doctor.
- Breastfeeding: it is not known whether enough is absorbed to reach breast milk.
The label also says to seek a doctor's advice straight away about continuing if you develop a new eye condition such as an injury or infection, have a sudden drop in vision, have eye surgery, or develop an eye reaction, "particularly conjunctivitis and eyelid reactions".
Common application mistakes
| Mistake | What the label says instead |
|---|---|
| Dripping straight from the bottle onto the lid | One drop on a sterile applicator, then drawn along the lid margin |
| Coating the lashes like mascara | Apply to the skin at the base of the lashes |
| Using one applicator for both eyes | A new sterile applicator for the second eye |
| Reusing an applicator or brush | Dispose of the applicator after one use |
| Adding the lower lash line | Do not apply to the lower eyelash line |
| Two drops, or twice a day, to speed things up | Additional applications will not increase growth |
| Leaving runoff on the skin | Blot excess with a tissue |
| Applying with contact lenses in | Remove lenses; reinsert after 15 minutes |
| Doubling up after a missed night | Do not catch up; apply the next evening |
| Rinsing the eye if a little gets in | Not expected to cause harm; do not rinse |
Careprost Plus is not an eyelash product
Careprost Plus, also from Sun Pharma, combines bimatoprost with timolol, a beta blocker. It is a glaucoma drop, and the second medicine is not part of the Latisse method or its trials. If you are buying for lashes, choose plain bimatoprost 0.03%, not Careprost Plus.
Can you use the same method on eyebrows?
The Latisse label covers the upper eyelashes and nothing else, and it specifically warns about hair growing where the solution repeatedly touches skin. Eyebrow use is off label. Our bimatoprost for eyebrows guide covers what those trials found and why the method is not the same.
Storage, and how long a bottle lasts
The Latisse label says to store the bottle at 2 to 25 °C (36 to 77 °F). Check the carton of your Careprost bottle for its own storage and after-opening instructions, and do not use it past the expiry date or if the solution looks cloudy.
What our bimatoprost bottles cost (28 October 2026)
These are the prices on our product pages as of 28 October 2026. All are 3 mL bottles of bimatoprost 0.03%. None of them is approved by the FDA for eyelashes. The Careprost pack we sell does not include applicators; check each product page for what comes in the pack, and plan on buying sterile single-use applicators separately.
| Product (maker) | Pack | Price | Per bottle |
|---|---|---|---|
| Careprost 3 mL (Sun Pharma) | 1 bottle | $9.00 | $9.00 |
| Latisse Generic 0.03% (Actiza) | 5 bottles | $40.00 | $8.00 |
| 10 bottles | $75.00 | $7.50 | |
| 20 bottles | $130.00 | $6.50 | |
| 40 bottles | $220.00 | $5.50 | |
| Lashona 3 mL (Actiza) | 5 bottles | $40.00 | $8.00 |
| 10 bottles | $70.00 | $7.00 | |
| 20 bottles | $120.00 | $6.00 | |
| Lashisma (Intas) | 2 bottles | $42.00 | $21.00 |
| 4 bottles | $70.00 | $17.50 | |
| 6 bottles | $100.00 | $16.67 |
Lashona is also sold in larger packs (40 to 100 bottles) on its product page. Shipping, according to our shipping page, is a flat $25 for standard registered shipping on orders under $149 and free on orders of $149 or more, with delivery times of 7 to 14 business days; customs fees, if any, are the responsibility of the recipient.
For comparison, the federal NADAC survey (effective 21 October 2026) puts what US pharmacies pay for a 3 mL Latisse bottle at about $122.91 ($40.96931 per mL) and for a 3 mL generic bimatoprost 0.03% eyelash solution at about $79.88 ($26.62833 per mL). Those are pharmacy acquisition costs, not counter prices; Latisse and the Sandoz generic are packed with sterile applicators. Our Latisse cost and insurance guide has more on US pricing.
Prescriptions and importing
In the US, Latisse and its generics are prescription medicines. The FDA's personal importation page says: "In most circumstances, it is illegal for individuals to import drugs or devices into the U.S. for personal use because these products purchased from other countries often have not been approved by the FDA for use and sale in the U.S." (FDA, Personal Importation). Careprost is not FDA approved. Rules differ by country and by situation, so check the position that applies to you before ordering. Our article Is Careprost legal in the USA? covers the US rules in detail, and Latisse vs bimatoprost explains how the brand and generic products relate. Every lash product we stock is listed on our eyelash growth page.
When to stop and see a doctor
- Eye pain, a red eye that does not settle, discharge or swelling, which may mean infection.
- Any sudden change or blurring of vision.
- A noticeable change in iris colour.
- Itching, rash or swelling of the eyelids that suggests an allergic reaction.
- Any planned eye surgery, or a new eye injury or infection.
- If you use glaucoma drops and have not yet discussed lash treatment with your eye doctor.
Sources
- LATISSE (bimatoprost ophthalmic solution) 0.03%, US prescribing information and patient information, AbbVie Inc. DailyMed setid 34f83d9d-2c64-463e-8a90-9a460fedfead, SPL version 25 (published 23 December 2025), accessed 28 October 2026: sections 2, 4, 5.1 to 5.8, 6.1, 6.2, 8.1, 8.2, 14, 16, 17 and patient information.
- Glaser DA, Hossain P, Perkins W, et al. Long-term safety and efficacy of bimatoprost solution 0.03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial. Br J Dermatol 2015;172(5):1384-94. PMID 25296533, PMC4832276: Tables 5 and 7.
- US Food and Drug Administration. Drugs@FDA via openFDA: NDA 022369 (Latisse), original approval 24 December 2008. NDC directory via openFDA: Latisse 0023-3616, Sandoz bimatoprost 0781-6206 packaging.
- Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC), weekly file as of 28 October 2026, rows effective 21 October 2026: NDC 00023361670 (Latisse 3 mL) and 62332051103 / 00781620693 (bimatoprost 0.03% eyelash solution 3 mL).
- US Food and Drug Administration. Personal Importation. https://www.fda.gov/industry/import-basics/personal-importation, accessed 28 October 2026.
- Netmeds (India). Careprost Eye Drops 3ml product listing: marketer Sun Pharmaceutical Industries Ltd, bimatoprost 0.03% w/v, antiglaucoma preparations, Schedule H, accessed 28 October 2026.
- SafeRxPills product pages and shipping page, prices and shipping terms as listed on 28 October 2026.
This guide is for information and does not replace advice from a doctor, optometrist or pharmacist who knows your eyes and medical history. If you use any eye pressure medicine, talk to your eye doctor before using bimatoprost on your lashes.
?Frequently Asked Questions
How do you apply Careprost to your eyelashes?
Follow the Latisse label method: once a night, with makeup and contact lenses removed, put one drop on a sterile single-use applicator and draw it along the skin at the base of the upper lashes, from the inner to the outer corner. Blot any excess, throw the applicator away and use a new one for the other eye.
Does Careprost come with applicators?
No. Careprost is sold in India as a glaucoma eye drop, and the 3 mL pack we sell has no applicators or lash instructions. Latisse in the US comes with 70 sterile, disposable applicators in the 3 mL pack. Careprost users need to buy sterile single-use applicators separately.
Can I use a mascara wand or eyeliner brush instead?
The Latisse label says not to reuse applicators and not to use any other brush or applicator, because reuse raises the risk of contamination and eye infection. A reused wand or brush goes against that rule. A fresh sterile single-use applicator for each eye is the closest match to the label.
Should I apply Careprost or Latisse to the lower lashes?
No. The label says do not apply to the lower eyelash line. Its warnings on eyelid skin darkening and hair growth outside the treatment area are the reason, and the trial results come from upper lid application.
How many drops of Careprost should I use?
One drop per eye, placed on the applicator rather than dripped onto the lid. The label says additional applications will not increase lash growth, and extra solution only adds runoff onto the skin.
Should I apply it in the morning or at night?
The label dose is once nightly, on a clean face with makeup and contact lenses removed. Using it more than once a day does not grow lashes faster.
What happens if Careprost or Latisse gets in my eye?
The Latisse label says it is not expected to cause harm if it gets into the eye, and that the eye should not be rinsed. See a doctor if the eye stays red or painful or your vision changes.
Can I wear contact lenses with bimatoprost?
Take soft lenses out before applying. Latisse contains benzalkonium chloride, which can be absorbed by soft lenses and discolour them. The label says lenses may go back in 15 minutes after application.
What if I miss a night?
Do not try to catch up or use extra. The Latisse patient leaflet says to apply it as usual the next evening.
How long until I see results from nightly application?
The label says the effect is gradual and not significant in most patients until 2 months. In the main trial, 15% had a visible gain at week 4, 50% at week 8 and 78% at week 16, against 8%, 15% and 18% on vehicle.
Can I use Careprost on my lashes if I use glaucoma eye drops?
Only after talking to your eye doctor. The Latisse label warns that in people using Lumigan or other prostaglandin analogs for eye pressure, adding it may interfere with the pressure lowering, and these patients should be monitored.
SafeRxPills Pharmacy Team
Pharmacist, Content, B.Pharm, M.Pharm, Rajiv Gandhi University
Pharmacist writing on antiparasitic, ophthalmic and dermatological generics. Focuses on what the regulatory labelling and published evidence actually support.
Comments (0)
Leave a Comment
No comments yet. Be the first to share your thoughts!
Related Articles

How Long Does Careprost Take to Work? Week by Week Results From the Latisse Trial
June 20, 2026


